HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

AbstractAIM:
To investigate the neuroprotective effects of morin on 1-methyl-4-phenylpyridinium ion (MPP(+))-induced apoptosis in neuronal differentiated PC12 cells as well as in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson disease (PD).
METHODS:
PC12 cells were challenged with MPP(+) in the presence or absence of morin. Cell viability was determined using MTT assay. Cell apoptosis was measured using flow cytometry. Generation of reactive oxygen species (ROS) was assayed using fluorescence assay. In an MPTP mouse model of PD, behavioral deficits, striatal dopamine content, and number of dopaminergic neurons were measured.
RESULTS:
MPP(+) induced apoptosis and ROS formation in PC12 cells. Concomitant treatment with morin (5-50 mumol/L) significantly attenuated the loss of cell viability and apoptosis when compared with MPP(+) treatment alone. Morin also attenuated ROS formation induced by MPP(+). MPTP induced permanent behavioral deficits and nigrostriatal lesions in mice. When administered prior to MPTP, morin (20 to 100 mg/kg) attenuated behavioral deficits, dopaminergic neuronal death and striatal dopamine depletion in the MPTP mouse model.
CONCLUSION:
The findings suggest that morin has neuroprotective actions both in vitro and in vivo, and may provide a novel therapeutic agent for the treatment of PD and other neurodegenerative diseases.
AuthorsZhen-tao Zhang, Xue-bing Cao, Nian Xiong, Hong-cai Wang, Jin-sha Huang, Sheng-gang Sun, Tao Wang
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 31 Issue 8 Pg. 900-6 (Aug 2010) ISSN: 1745-7254 [Electronic] United States
PMID20644549 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiparkinson Agents
  • Flavonoids
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • morin
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • 1-Methyl-4-phenylpyridinium
  • Dopamine
Topics
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • 1-Methyl-4-phenylpyridinium
  • Animals
  • Antiparkinson Agents (administration & dosage, pharmacology)
  • Apoptosis (drug effects)
  • Cell Survival (drug effects)
  • Dopamine (metabolism)
  • Dose-Response Relationship, Drug
  • Flavonoids (administration & dosage, pharmacology)
  • Flow Cytometry
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuroprotective Agents (administration & dosage, pharmacology)
  • PC12 Cells
  • Parkinsonian Disorders (drug therapy, physiopathology)
  • Rats
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: